Longitudinal evaluation of endothelial function in children and adolescents with type 1 diabetes mellitus: A long-term follow-up study

Pediatrics International

Volumn 56, Issue 2, 2014, Pages 188-195

  Bruzzi, Patrizia ^a   Predieri, Barbara ^a   Patianna, Viviana Dora ^a   Salvini, Annamaria ^a   Rossi, Rosario ^a   Modena, Maria Grazia ^a   Iughetti, Lorenzo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

atherosclerosis; endothelial function; flow mediated dilation; glycosylated hemoglobin; type 1 diabetes mellitus

Indexed keywords

ADOLESCENT; ADRENERGIC SYSTEM; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LONGITUDINAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; PATHOPHYSIOLOGY; RISK FACTOR; TIME; VASCULAR ENDOTHELIUM;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; RISK FACTORS; TIME FACTORS;

EID: 84904726323     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12220     Document Type: Article

References (53)

1. Järvisalo MJ, Raitakari M., Toikka JO, Putto-Laurila A, Rontu R, Laine S,. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 2004; 109: 1750-1755.
2. Nathan DM,. Long-term complications of diabetes mellitus. N. Engl. J. Med. 1993; 328: 1676-1685.
3. Peña AS, Couper JJ, Harrington J, et al. Hypoglycemia, but not glucose variability, relates to vascular function in children with type 1 diabetes. Diabetes Technol. Ther. 2012; 14: 457-462.
4. Jarvisalo MJ, Putto-Laurila A, Jartti L, et al. Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes 2002; 51: 493-498.
5. Orchard TJ, Costacou T, Kretowski A, Nesto RW,. Type 1 diabetes and coronary artery disease. Diabetes Care 2006; 29: 2528-2539.
6. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.
7. Deanfield JE, Halcox JP, Rabelink TJ,. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007; 115: 1285-1295.
8. Bruyndonckx L, Hoymans VY, Van Craenenbroeck AH, et al. Assessment of endothelial dysfunction in childhood obesity and clinical use. Oxid. Med. Cell. Longev. 2013. doi: 10.1155/2013/174782
9. Ebara T, Conde K, Kako Y, et al. Delayed catabolism of apoB-48 lipoproteins due to decreased heparin sulfate proteoglycan production in diabetic mice. J. Clin. Invest. 2000; 105: 1807-1818.
10. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute, NIH Publication 01-3670, 2001.
11. Kavey REW, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high-risk pediatric patients. Circulation 2006; 114: 2710-2738.
12. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002; 287: 2563-2569.
13. Nathan DM, Cleary PA, Backlund JY, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 2005; 353: 2643-2653.
14. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J. Pediatr. 1994; 125: 177-188.
15. Danne T, Mortensen HB, Hougaard P, et al. Persistent differences among centers over 3 years in glycemic control and hypoglycaemia in a study of 3805 children and adolescents with type 1 diabetes from the Hvidore Study Group. Diabetes Care 2001; 24: 1342-1347.
16. Mortensen HB, Hougaard P,. Comparison of metabolic control in a cross-sectional study of 2873 children and adolescents with IDDM from 18 countries. The Hvidore Study Group on Childhood Diabetes. Diabetes Care 1997; 20: 714-720.
17. Springer D, Dziura J, Tamborlane WV, et al. Optimal control of type 1 diabetes mellitus in youth receiving intensive treatment. J. Pediatr. 2006; 149: 227-232.
18. Silverstein JH, Klingensmith G, Copeland K, et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005; 28: 186-212.
19. Mahmud F, Earing MG, Lee RA, Lteif AN, Driscoll DJ, Lerman A,. Altered endothelial function in asymptomatic male adolescents with type 1 diabetes. Congenit. Heart Dis. 2006; 1: 98-103.
20. Marshall WA, Tanner JM,. Variations in pattern of pubertal changes in girls. Arch. Dis. Child. 1969; 44: 291-303.
21. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2010; 33: S11-S61.
22. Sorensen KE, Celermajer DS, Spiegelhalter DJ, et al. Non-invasive measurement of human endothelium dependent responses: accuracy and reproducibility. Br. Heart J. 1995; 74: 247-253.
23. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 2002; 39: 257-265.
24. Rossi R, Nuzzo A, Origliani G, Modena MG,. Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J. Am. Coll. Cardiol. 2008; 51: 997-1002.
25. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA,. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N. Engl. J. Med. 1998; 338: 1650-1656.
26. Davis PH, Dawson JD, Riley WA, Lauer RM,. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 2001; 104: 2815-2819.
27. Cho YH, Couper JJ, Donaghue KC,. Complications of childhood diabetes and the role of technology. Pediatr. Endocrinol. Rev. 2010; 7 (S3): 422-431.
28. Giannini C, Mohn A, Chiarelli F, Kelnar CJ,. Macrovascular angiopathy in children and adolescents with type 1 diabetes. Diabetes Metab. Res. Rev. 2011; 27: 436-460.
29. Donaghue KC, Robinson J, McCredie R, Fung A, Silink M, Celermajer DS,. Large vessel dysfunction in diabetic adolescents and its relationship to small vessel complications. J. Pediatr. Endocrinol. Metab. 1997; 10: 593-598.
30. Meeking DR, Cummings MH, Thorne S, et al. Endothelial dysfunction in type 2 diabetic subjects with and without microalbuminuria. Diabet. Med. 1999; 16: 841-847.
31. Hooper WC, Catravas JD, Heistad DD, Sessa WC, Mensah GA,. Vascular endothelium summary statement I: health promotion and chronic disease prevention. Vasc. Pharmacol. 2007; 46: 315-317.
32. Singh TP, Groehn H, Kazmers A,. Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 2003; 41: 661-665.
33. Wiltshire EJ, Gent R, Hirte C, Pena A, Thomas DW, Couper JJ,. Endothelial dysfunction relates to folate status in children and adolescents with type 1 diabetes. Diabetes 2002; 51: 2282-2286.
34. Babar GS, Zidan H, Widlansky ME, et al. Impaired endothelial function in preadolescent children with type 1 diabetes. Diabetes Care 2011; 34: 681-685.
35. Harrington J, Pena AS, Gent R, Hirte C, Couper J,. Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus. J. Pediatr. 2010; 156: 237-241.
36. Clarkson P, Celermajer DS, Donald AE, et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J. Am. Coll. Cardiol. 1996; 28: 573-579.
37. Poredos P, Kek Ljubec A, Poredos P, Visnovic Poredos A,. Endothelial dysfunction predictor of structural changes of arterial wall in type I diabetes. Int. Angiol. 2006; 25: 280-286.
38. Cè GV, Rohde LE, da Silva AM, Punales MK, de Castro AC, Bertoluci MC,. Endothelial dysfunction is related to poor glycemic control in adolescents with type 1 diabetes under 5 years of disease: evidence of metabolic memory. J. Clin. Endocrinol. Metab. 2011; 96: 1493-1499.
39. Ceriello A, Ihnat MA, Thorpe JE,. Clinical review 2: the "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? J. Clin. Endocrinol. Metab. 2009; 94: 410-415.
40. Odermarsky M, Nilsson A, Lernmark A, Sjoblad S, Liuba P,. Atherogenic vascular and lipid phenotypes in young patients with type 1 diabetes are associated with diabetes high-risk HLA genotype. Am. J. Physiol. Heart Circ. Physiol. 2007; 293: H3175-H3179.
41. Stroes SE, van Faassen EE, Yo M, et al. Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ. Res. 2000; 86: 1129-1134.
42. MacKenzie KE, Wiltshire EJ, Gent R, Hirte C, Piotto L, Couper JJ,. Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus. Pediatrics 2006; 118 (1): 242-253.
43. Trigona B, Aggoun Y, Maggio A, et al. Preclinical noninvasive markers of atherosclerosis in children and adolescents with type 1 diabetes are influenced by physical activity. J. Pediatr. 2010; 157: 533-539.
44. Seeger JPH, Thijssen DHJ, Noordam K, Cranen MEC, Hopman MT, Nijhuis-van der Sanden MW,. Exercise training improves physical fitness and vascular function in children with type 1 diabetes. Diabetes Obes. Metab. 2011; 13: 382-384.
45. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Karas RH,. Comparison of flow-mediated dilatation of the brachial artery in coronary patients with low-density lipoprotein cholesterol levels <80 mg/dl versus patients with levels 80 to 100 mg/dl. Am. J. Cardiol. 2005; 95: 93-95.
46. Suys B, de Beeck LO, Rooman R, et al. Impact of oxidative stress on the endothelial dysfunction of children and adolescents with type 1 diabetes mellitus: protection by superoxide dismutase? Pediatr. Res. 2007; 62: 456-461.
47. Glowinska-Olszewska B, Moniuszko M, Hryniewicz A, et al. Relationship between circulating endothelial progenitor cells (EPCs) and endothelial dysfunction in children with type 1 diabetes-a novel paradigm of early atherosclerosis in high-risk young patients. Eur. J. Endocrinol. 2013; 168: 153-161.
48. Mamhud FH, Earing MG, Lee RA, Lteif AN, Driscoll DJ, Lerman A,. Altered endothelial function in asymptomatic male adolescents with type 1 diabetes. Congenit. Heart Dis. 2006; 1: 98-103.
49. Mizia-Stec K, Zbigniew G, Mizia M, et al. Flow-mediated dilation and gender in patients with coronary artery disease: arterial size influences gender differences in flow-mediated dilation. Echocardiography 2007; 24: 1051-1057.
50. Marra G, Cotroneo P, Pitocco D, et al. Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care 2002; 5: 370-375.
51. Jarvisalo MJ, Raitakari OT,. Ultrasound assessment of endothelial function in children. Vasc. Health Risk Manag. 2005; 1: 227-233.
52. McNeal CJ, Wilson DP, Christou D, et al. The use of surrogate vascular markers in youth at risk for premature cardiovascular disease. J. Pediatr. Endocrinol. Metab. 2009; 22: 195-211.
53. Redberg R, Vogel R, Criqui M, Herrington D, Lima J, Roman M,. 34th Bethesda Conference: task force #3-what is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis? J. Am. Coll. Cardiol. 2003; 41: 1886-1898.